Developing Intermediary Medication Phenotypes via Metabolomics Biotechnology Using an Electronic Health Record-Linked Biobank

Matthew K. Breitenstein, Richard M. Weinshilboum, Jyotishman Pathak, Liewei Wang. Developing Intermediary Medication Phenotypes via Metabolomics Biotechnology Using an Electronic Health Record-Linked Biobank. In AMIA 2015, American Medical Informatics Association Annual Symposium, San Francisco, CA, USA, November 14-18, 2015. AMIA, 2015. [doi]

@inproceedings{BreitensteinWPW15,
  title = {Developing Intermediary Medication Phenotypes via Metabolomics Biotechnology Using an Electronic Health Record-Linked Biobank},
  author = {Matthew K. Breitenstein and Richard M. Weinshilboum and Jyotishman Pathak and Liewei Wang},
  year = {2015},
  url = {http://knowledge.amia.org/59310-amia-1.2741865/t005-1.2744350/f005-1.2744351/2247129-1.2745364/2248751-1.2745361},
  researchr = {https://researchr.org/publication/BreitensteinWPW15},
  cites = {0},
  citedby = {0},
  booktitle = {AMIA 2015, American Medical Informatics Association Annual Symposium, San Francisco, CA, USA, November 14-18, 2015},
  publisher = {AMIA},
}